Maria E Santaella, Sammie Valadez, Esmeralda Vázquez, Halli Benasutti, Samantha A Carlson, Donna DiMichele, Keri L Norris, Fiona Robinson, Leonard A Valentino, Michelle L Witkop, Michael Recht
{"title":"Bleeding Disorders Research Collaborative: an opportunity for impact.","authors":"Maria E Santaella, Sammie Valadez, Esmeralda Vázquez, Halli Benasutti, Samantha A Carlson, Donna DiMichele, Keri L Norris, Fiona Robinson, Leonard A Valentino, Michelle L Witkop, Michael Recht","doi":"10.1080/17474086.2026.2688871","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The National Research Blueprint proposes a Bleeding Disorders Research Collaborative (BDRC) centering people, priorities, and principles. Driven by community-identified unmet needs, the National Bleeding Disorders Foundation (NBDF) coordinated a five-year co-creation endeavor engaging a multitude of diverse stakeholders.</p><p><strong>Areas covere: </strong>Seven multidisciplinary working groups built upon previous NBDF State of the Science Summit conclusions to draft a blueprint of the research and development, workforce, infrastructure, community engagement, policy, Lived Experience Expert, and health equity, diversity, and inclusion elements of the novel research collaborative. Implementing their proposal will engage the entire inheritable bleeding disorders community mobilizing all its expertise, resources, champions, and partners. Education, training, and mentorship will be key in empowering diverse research teams working together in respectful partnership.</p><p><strong>Expert opinion: </strong>The proposed BDRC has the potential to transform inheritable bleeding disorders research through its collaborative infrastructure centering lived experience expertise and health equity, diversity, and inclusion to efficiently advance health justice for the entire community.</p>","PeriodicalId":12325,"journal":{"name":"Expert Review of Hematology","volume":"19 sup1","pages":"7-22"},"PeriodicalIF":2.8000,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Review of Hematology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/17474086.2026.2688871","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/8/6 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: The National Research Blueprint proposes a Bleeding Disorders Research Collaborative (BDRC) centering people, priorities, and principles. Driven by community-identified unmet needs, the National Bleeding Disorders Foundation (NBDF) coordinated a five-year co-creation endeavor engaging a multitude of diverse stakeholders.
Areas covere: Seven multidisciplinary working groups built upon previous NBDF State of the Science Summit conclusions to draft a blueprint of the research and development, workforce, infrastructure, community engagement, policy, Lived Experience Expert, and health equity, diversity, and inclusion elements of the novel research collaborative. Implementing their proposal will engage the entire inheritable bleeding disorders community mobilizing all its expertise, resources, champions, and partners. Education, training, and mentorship will be key in empowering diverse research teams working together in respectful partnership.
Expert opinion: The proposed BDRC has the potential to transform inheritable bleeding disorders research through its collaborative infrastructure centering lived experience expertise and health equity, diversity, and inclusion to efficiently advance health justice for the entire community.
期刊介绍:
Advanced molecular research techniques have transformed hematology in recent years. With improved understanding of hematologic diseases, we now have the opportunity to research and evaluate new biological therapies, new drugs and drug combinations, new treatment schedules and novel approaches including stem cell transplantation. We can also expect proteomics, molecular genetics and biomarker research to facilitate new diagnostic approaches and the identification of appropriate therapies. Further advances in our knowledge regarding the formation and function of blood cells and blood-forming tissues should ensue, and it will be a major challenge for hematologists to adopt these new paradigms and develop integrated strategies to define the best possible patient care. Expert Review of Hematology (1747-4086) puts these advances in context and explores how they will translate directly into clinical practice.